Table S1 - Cost-Effectiveness of Genotypic Antiretroviral Resistance Testing in HIV-Infected Patients with Treatment Failure

Transition probability matrix for HIV disease progression generated by pooling consecutive six-month observations from patients on HAART enrolled in the SHCS between 1996–2004. Numbers indicate observations, the likelihood is shown in brackets. To calculate the posterior probability with a non-informative prior, the number of observations in each cell with an allowed transition is increased by one.
(0.05 MB DOC)